Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
162 hedge funds and large institutions have $831M invested in Taro Pharmaceutical Industries Ltd. in 2016 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 50 reducing their positions, and 21 closing their positions.
25% more call options, than puts
Call options by funds: $1.02M | Put options by funds: $818K
24% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 50
24% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 21
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
2% more funds holding
Funds holding: 159 → 162 (+3)
19% less capital invested
Capital invested by funds: $1.02B → $831M (-$194M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carmignac Gestion
Paris,
France
|
+$34.6M |
| 2 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$22.7M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
+$15.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.6M |
| 5 |
Morgan Stanley
New York
|
+$9.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$29.6M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$22M |
| 3 |
Goldman Sachs
New York
|
-$7.97M |
| 4 |
RIA
RPG Investment Advisory
Pleasanton,
California
|
-$5.95M |
| 5 |
HI
HBK Investments
Dallas,
Texas
|
-$4.67M |
TARO Hedge Fund Activity: Q3 2016 in Review
162 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2016, worth a combined $831M — down 19% from $1.02B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new TARO positions and 21 closed out — a net gain of 5 holders — while 62 added to existing stakes and 50 trimmed.
The largest buyer was Carmignac Gestion, opening a new position worth an estimated $34.6M. The largest seller was Acadian Asset Management, cutting an estimated $29.6M.
- 162 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2016, up from 159 in Q2 2016.
- Funds reported $831M of Taro Pharmaceutical Industries Ltd. stock for Q3 2016, down 19% quarter-over-quarter.
- 26 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2016 and 21 closed out, a net change of +5 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2016 was Carmignac Gestion, an estimated $34.6M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2016 was Acadian Asset Management, an estimated $29.6M sold.
Based on aggregated 13F filings for Q3 2016.